Understanding mRNA Production: The Key to Modern Medicine

Messenger ribonucleic acid (mRNA) is a single-stranded molecule, which carries coding sequence and plays a prominent role in protein synthesis. It transfers genetic information form to DNA to ribosomes, a specialized structure, or organelle, which decodes genetic information into a protein. Despite the challenges associated, there is a growing need for mRNA production service providers. In the foreseen future, as more of such RNA-based leads mature and move into the clinic and / or get commercialized, we anticipate the mRNA synthesis and mRNA manufacturing market to witness healthy market growth during the forecast period.

Structure of mRNA

Post the onset of the COVID-19 pandemic mRNA has emerged as promising therapeutic tool in modern healthcare industry. With the help of genetic engineering, synthetic mRNAs can express proteins, as they structurally resemble a natural mRNA. Presently, more than 195 mRNA therapeutics / mRNA vaccines are under development or commercialized for the treatment of a variety of indications. As a result, there is an evident increase in the demand for mRNA production capacity.

Structure of mRNA - Roots Analysis

Application of Synthetic mRNA

Several studies conducted by healthcare companies and research institutions have demonstrated the potential of mRNA. The key applications of mRNAs are below:

Roots Analysis different applications for  mRNA production - explains various areas

Growing Demand for mRNA Manufacturing and mRNA Production Service Providers

The mRNA manufacturing process is a complex process which is associated with several challenges.  The mRNA production requires skilled labor, stringent manufacturing protocols and specialized expertise. Further, the biggest challenge in mRNA production is the purification which involve the use of hazardous solvents / materials and stability of drug products (thereby, requiring specialized facilities and cold chain transportation). Additionally, they also require appropriate drug delivery systems to efficiently administer the intervention (in a manner that they can avoid degradation by cellular endonucleases). However, because of such operational and technical challenges associated with the mRNA manufacturing, several products innovators in the biopharmceutical industry are increasingly relying on the contract service providers.

Competitive Landscape of mRNA Production Companies

Presently, mRNA production mRNA production service providers landscape features a mix of over 70 large, mid-sized and small companies, which claim to have the required expertise to offer various services for the synthesis and production of mRNAs across different scales of operations, worldwide. In addition to this, more than 95 mRNA synthesis kits, that contain reagents for the synthesis of research grade mRNAs, are currently available in the market. Recent developments in this segment of the biopharmaceutical industry indicate that the service providers are upgrading their capabilities and infrastructure to accommodate the current and anticipated demand for this novel class of biologics.

List of mRNA production Service Providers - Roots Analysis

Concluding Remarks

Currently, dozens of preclinical and clinical reports demonstrating the efficacy of these platforms have been published in the last two years alone. However, owing to the several challenges associated with the production of mRNA therapeutics and vaccine market, majority of the pharmaceutical companies prefer to outsource their mRNA production operations. In the foreseen future, as more of such RNA-based leads mature and move into the clinic and / or get commercialized, we anticipate the mRNA manufacturing services market to witness healthy growth.

For further information on this market, access the SAMPLE PAGES on our latest mRNA synthesis and mRNA manufacturing market report.